Neurogene Price Chart
Neurogene Volume Chart
Neurogene Market Segments
After Hours
+0.00(+0.00%)
| Open | $32.00 |
|---|---|
| Close | $32.00 |
| Low | $32.00 |
| Low Change | 0.00 (0.00%) |
| High | $32.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $3.20K |
Regular Trading Hours
+0.47(+1.54%)
| Open | $30.47 |
|---|---|
| Close | $30.94 |
| Low | $29.63 |
| Low Change | -0.84 (-2.76%) |
| High | $31.84 |
| High Change | +1.37 (+4.50%) |
| Range | $2.21 |
| Volume | 120.769K |
| Dollar Volume | $3.74M |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
-1.03(-3.19%)
| Open | $32.30 |
|---|---|
| Close | $31.27 |
| Low | $29.62 |
| Low Change | -2.68 (-8.30%) |
| High | $33.53 |
| High Change | +1.23 (+3.81%) |
| Range | $3.91 |
| Volume | 127.012K |
| Dollar Volume | $3.97M |
Premarket Yesterday
*No Trades in Segment
Neurogene Moving Averages
| 5 Day Moving Average (SMA5) | $29.54 |
|---|---|
| 10 Day Moving Average (SMA10) | $28.16 |
| 20 Day Moving Average (SMA20) | $26.40 |
| 50 Day Moving Average (SMA50) | $23.32 |
| 100 Day Moving Average (SMA100) | $20.99 |
| 200 Day Moving Average (SMA200) | $21.97 |
Neurogene Statistics
| Average Volume (30 Days) | 164.63K |
|---|---|
| P/E Ratio (Current) | -5.58 |
| EPS (Current) | -$5.79 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$78.36M |
| Cash Ratio | 6.33 |
| Current Ratio | 16.56 |
| Quick Ratio | 16.56 |
| Debt to Equity | 0.00 |
| Enterprise Value | $401.03M |
| EV to EBITDA | -4.00 |
| EV to Sales | — |
| Price to Book | 1.91 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.31% |
| Return on Equity | -0.34% |
Neurogene Stock Splits
There has been 1 stock split for Neurogene (NGNE). The reverse stock split occured on September 25, 2023 and reduced the outstanding shares at a ratio of 5:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 25, 2023 | Reverse | 5:1 |
Neurogene Dividends
There have been no dividends for Neurogene (NGNE).